Continuum Advisory’s Bausch Health BHC Stock Holding History

Continuum Advisory’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-68	Closed	-$473	–	1710
2024 Q1	$473	Buy	+68	New	+$595	﹤0.01%	1613

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Continuum Advisory's BHC Position: Q2 2024 in Review

Continuum Advisory sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 68 shares — an estimated $473 sold.

Continuum Advisory first reported a position in BHC in Q1 2024 and held it in 1 quarter. The position peaked at $473 in Q1 2024. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

Continuum Advisory reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
Continuum Advisory sold 68 Bausch Health shares in Q2 2024, an estimated $473.
Continuum Advisory first reported a position in Bausch Health in Q1 2024 and held it in 1 quarter.
Continuum Advisory's Bausch Health position peaked at $473 in Q1 2024.
234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on Continuum Advisory's 13F filing for Q2 2024, filed 19 Jul 2024.